A digital tool to help middle-aged adults with Type 1 diabetes exercise safely
Informatics-Based Digital Application to Promote Safe Exercise in Middle-Aged Adults with Type 1 Diabetes
['FUNDING_CAREER'] · YALE UNIVERSITY · NIH-10911997
This study is creating a helpful app for middle-aged adults with Type 1 diabetes to make exercising easier and safer by giving them personalized tips and support based on their blood sugar levels.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-10911997 on ClinicalTrials.gov |
What this research studies
This research aims to develop a digital application that supports middle-aged adults with Type 1 diabetes in safely engaging in exercise. It addresses the unique challenges these individuals face, such as managing blood glucose levels and overcoming psychosocial barriers to physical activity. The approach includes using continuous glucose monitoring data to provide personalized feedback and just-in-time support through automated text messages. By enhancing adherence to exercise routines, the application seeks to improve overall health outcomes for participants.
Who could benefit from this research
Good fit: Ideal candidates for this research are middle-aged adults aged 21 and older who have been diagnosed with Type 1 diabetes.
Not a fit: Patients who are not middle-aged or do not have Type 1 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved exercise adherence and better health outcomes for middle-aged adults with Type 1 diabetes.
How similar studies have performed: Previous research has shown promise in using digital tools for diabetes management, indicating potential success for this innovative approach.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ASH, GARRETT IGO — YALE UNIVERSITY
- Study coordinator: ASH, GARRETT IGO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.